Strategy Signal, an independent biotech equity research firm, has teamed with Analyst Hub for key business infrastructure components to create a new, institutional-facing research firm. With Analyst Hub providing compliance, distribution, sales, marketing, middle- and back-office infrastructure, Strategy Signal operates with the highest quality standards for equity research.
Strategy Signal is providing proprietary fundamental quantitative research to institutional investors that target substantial growth opportunities – adding significant value while minimizing risk. The goal of Strategy Signal is to increase returns on investments in biotechnology by improving selection methods optimized for fundamentals, timeliness and risk mitigation. Strategy Signal is focused on delivering results that improve the organization, efficiency and ease of tracking investments and trades.
To accomplish this, Strategy Signal overlays a proprietary methodology on a strong foundation of fundamental and strategic knowledge to select equity investments with a higher likelihood of substantial appreciation within a defined time period. Using Strategy Signal’s proprietary methodology, investors may improve capital allocation, investment efficiency and effectiveness.